Immunoprecise Antibodies Ltd (IPA)

Nov 13, 2024

ImmunoPrecise's Breakthrough Cancer Treatment Shows Promise in $20.7B ADC Market | IPA Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Immunoprecise Antibodies Ltd (IPA-Q) QuotePress Release - The Globe and Mail

Nov 13, 2024

Nov 05, 2024

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation - BioSpace

Nov 05, 2024

Oct 28, 2024

ImmunoPrecise Pummeled Despite Advancing Anti-Aging Research with Mayo - Baystreet.ca

Oct 28, 2024

Oct 28, 2024

ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology - Business Wire

Oct 28, 2024

Oct 24, 2024

ImmunoPrecise Antibodies Announces Annual Meeting Plans - TipRanks

Oct 24, 2024

Oct 21, 2024

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - BioSpace

Oct 21, 2024

Oct 21, 2024

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology - Pharmaceutical Technology

Oct 21, 2024

Oct 21, 2024

ImmunoPrecise Antibodies to Join AI Drug Summit - TipRanks

Oct 21, 2024

Oct 11, 2024

ImmunoPrecise Sets Virtual AGM for November 2024 - TipRanks

Oct 11, 2024

Oct 10, 2024

ImmunoPrecise Heralds Nobel Win, AI-Driven Biotherapeutics - TipRanks

Oct 10, 2024

Oct 10, 2024

ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design - Business Wire

Oct 10, 2024

Oct 09, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amid ... - Yahoo Finance

Oct 09, 2024

Oct 07, 2024

Financial Metrics Exploration: Understanding ImmunoPrecise Antibodies Ltd (IPA) Through Ratios - The Dwinnex

Oct 07, 2024

Oct 07, 2024

ImmunoPrecise Antibodies Ltd (IPA) Stock: A Year of Market Fluctuations - The InvestChronicle

Oct 07, 2024

Oct 03, 2024

Take off with ImmunoPrecise Antibodies Ltd (IPA): Get ready for trading - SETE News

Oct 03, 2024

Oct 03, 2024

ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer - Yahoo Finance

Oct 03, 2024

Oct 02, 2024

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus - BioSpace

Oct 02, 2024

Oct 02, 2024

ImmunoPrecise Advances Cancer Therapy with Biotheus Partnership - TipRanks

Oct 02, 2024

Oct 01, 2024

Have you been able to find a good deal on ImmunoPrecise Antibodies Ltd’s shares? - US Post News

Oct 01, 2024

Oct 01, 2024

ImmunoPrecise Antibodies Ltd (IPA)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Oct 01, 2024

Sep 26, 2024

ImmunoPrecise’s Breakthroughs in Cancer Antibody Therapies - TipRanks

Sep 26, 2024

Sep 26, 2024

ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments - StockTitan

Sep 26, 2024

Sep 23, 2024

ImmunoPrecise Sets Virtual Annual General Meeting - TipRanks

Sep 23, 2024

Sep 23, 2024

Ratio Review: Analyzing ImmunoPrecise Antibodies Ltd (IPA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 23, 2024

Sep 23, 2024

Was ImmunoPrecise Antibodies Ltd (IPA)’s session last reading good? - US Post News

Sep 23, 2024

Sep 18, 2024

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2025 Earnings Call Transcript - Insider Monkey

Sep 18, 2024

Sep 18, 2024

ImmunoPrecise Unveils Executive Compensation Strategy - TipRanks

Sep 18, 2024

Sep 17, 2024

IPA Stock Update: ImmunoPrecise Antibodies Ltd’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Sep 17, 2024

Sep 17, 2024

Earnings call: ImmunoPrecise announces mixed Q1 results, eyes future growth - Investing.com Australia

Sep 17, 2024

Sep 17, 2024

Post-Trade Analysis: ImmunoPrecise Antibodies Ltd (IPA) Slides -19.12, Closing at 0.54 - The Dwinnex

Sep 17, 2024

Sep 17, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q1 2025 Earnings Call Transcript Highlights: Revenue Growth ... - Yahoo Finance UK

Sep 17, 2024

Sep 17, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q1 2025 Earnings Call Transcript Highlights: Revenue Growth ... By GuruFocus - Investing.com Canada

Sep 17, 2024

Sep 16, 2024

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates - MSN

Sep 16, 2024

Sep 16, 2024

ImmunoPrecise Achieves AI-Driven Growth Amidst Challenges - TipRanks

Sep 16, 2024

Sep 16, 2024

ImmunoPrecise Advances Biotherapeutic Research Efficiency - TipRanks

Sep 16, 2024

Sep 16, 2024

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 - Business Wire

Sep 16, 2024

Sep 13, 2024

Earnings To Watch: ImmunoPrecise Antibodies Ltd (IPA) Reports Q1 2025 Result - GuruFocus.com

Sep 13, 2024

Sep 09, 2024

ImmunoPrecise Announces Upcoming Earnings Call - TipRanks

Sep 09, 2024

Sep 09, 2024

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024 - Business Wire

Sep 09, 2024

Aug 26, 2024

ImmunoPrecise Joins Prestigious Global Investment Conference - TipRanks

Aug 26, 2024

Aug 26, 2024

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York - Business Wire

Aug 26, 2024

Aug 23, 2024

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements - StockTitan

Aug 23, 2024

Aug 19, 2024

ImmunoPrecise Antibodies Successfully Engineers in silico Antibodies to Elusive Tumor Protein Using Its Patented LENSai Technology - Chronicle-Tribune

Aug 19, 2024

Aug 17, 2024

Short Interest in ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Declines By 14.4% - Defense World

Aug 17, 2024

Aug 16, 2024

Benchmark Lowers ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target to $3.00 - Defense World

Aug 16, 2024

Aug 14, 2024

Immunoprecise shares target cut, rating held on market volatility - Investing.com

Aug 14, 2024